{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:58:51Z","timestamp":1793321931192,"version":"4.5.0"},"reference-count":228,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.canlet.2024.217096","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T22:16:30Z","timestamp":1720044990000},"page":"217096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"special_numbering":"C","title":["Gut microbial metabolites in lung cancer development and immunotherapy: Novel insights into gut-lung axis"],"prefix":"10.1016","volume":"598","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6337-2672","authenticated-orcid":false,"given":"Xinpei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.canlet.2024.217096_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.canlet.2024.217096_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216365","article-title":"Circulating tumor DNA as liquid biopsy in lung cancer: biological characteristics and clinical integration","volume":"577","author":"Li","year":"2023","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.canlet.2024.217096_bib3","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1021\/acsnano.3c11147","article-title":"Single-cell liquid biopsy of lung cancer: ultra-simplified efficient enrichment of circulating tumor cells and hand-held fluorometer portable testing","volume":"18","author":"He","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2024.217096_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216239","article-title":"Tackling the current dilemma of immunotherapy in extensive-stage small cell lung cancer: a promising strategy of combining with radiotherapy","volume":"565","author":"Kang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217096_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216245","article-title":"Exosomal circRNAs in cancer: implications for therapy resistance and biomarkers","volume":"566","author":"Lin","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217096_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216021","article-title":"Macrophage xCT deficiency drives immune activation and boosts responses to immune checkpoint blockade in lung cancer","volume":"554","author":"Tang","year":"2023","journal-title":"Cancer Lett."},{"issue":"28","key":"10.1016\/j.canlet.2024.217096_bib7","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1200\/JCO.22.00825","article-title":"Therapy for stage IV non-small-cell lung cancer without driver alterations: ASCO living guideline","volume":"40","author":"Singh","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2024.217096_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2024.04.006","article-title":"Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities","author":"Konen","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"issue":"7164","key":"10.1016\/j.canlet.2024.217096_bib9","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nature06244","article-title":"The human microbiome project","volume":"449","author":"Turnbaugh","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.canlet.2024.217096_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/nu12020469","article-title":"Nutrients and microbiota in lung diseases of prematurity: the placenta-gut-lung triangle","volume":"12","author":"Piersigilli","year":"2020","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.canlet.2024.217096_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167120","article-title":"Multi-OMICS approaches in cancer biology: new era in cancer therapy","volume":"1870","author":"Chakraborty","year":"2024","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"issue":"9","key":"10.1016\/j.canlet.2024.217096_bib12","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1136\/gutjnl-2019-318556","article-title":"International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis","volume":"68","author":"Scott","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2024.217096_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216039","article-title":"Gut microbiota and colorectal cancer metastasis","volume":"555","author":"Zheng","year":"2023","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.canlet.2024.217096_bib14","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.4014\/jmb.2002.02032","article-title":"The inhibitory effect of gut microbiota and its metabolites on colorectal cancer","volume":"30","author":"Chen","year":"2020","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.canlet.2024.217096_bib15","article-title":"Alterations in the gut microbiota and their metabolites in colorectal cancer: recent progress and future prospects","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"issue":"23","key":"10.1016\/j.canlet.2024.217096_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202205563","article-title":"Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer","volume":"10","author":"Qu","year":"2023","journal-title":"Adv. Sci."},{"issue":"16","key":"10.1016\/j.canlet.2024.217096_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169490","article-title":"Gut metabolites and breast cancer: the continuum of dysbiosis, breast cancer risk, and potential breast cancer therapy","volume":"23","author":"Jaye","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.canlet.2024.217096_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411611","article-title":"Gut microbiota, metabolome, and body composition signatures of response to therapy in patients with advanced melanoma","volume":"24","author":"Vandoni","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.canlet.2024.217096_bib19","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.neo.2017.08.004","article-title":"Metagenomic shotgun sequencing and unbiased metabolomic profiling identify specific human gut microbiota and metabolites associated with immune checkpoint therapy efficacy in melanoma patients","volume":"19","author":"Frankel","year":"2017","journal-title":"Neoplasia"},{"issue":"6575","key":"10.1016\/j.canlet.2024.217096_bib20","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1126\/science.aaz7015","article-title":"Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response","volume":"374","author":"Spencer","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.canlet.2024.217096_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fmicb.2020.00301","article-title":"The cross-talk between gut microbiota and lungs in common lung diseases","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.canlet.2024.217096_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.725284","article-title":"Specific gut microbiome and serum metabolome changes in lung cancer patients","volume":"11","author":"Zhao","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12967-020-02231-0","article-title":"Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment","volume":"18","author":"Botticelli","year":"2020","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.canlet.2024.217096_bib24","article-title":"Modulating gut microbiome in cancer immunotherapy: harnessing microbes to enhance treatment efficacy","volume":"5","author":"Kang","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.canlet.2024.217096_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216152","article-title":"Ferroptosis: promising approach for cancer and cancer immunotherapy","volume":"561","author":"Zheng","year":"2023","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib26","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1002\/imt2.156","article-title":"Gut microbiota reshapes cancer immunotherapy efficacy: mechanisms and therapeutic strategies","volume":"3","author":"Xie","year":"2024","journal-title":"iMeta"},{"issue":"29","key":"10.1016\/j.canlet.2024.217096_bib27","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","article-title":"Role of the normal gut microbiota","volume":"21","author":"Jandhyala","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.canlet.2024.217096_bib28","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1042\/BCJ20160510","article-title":"Introduction to the human gut microbiota","volume":"474","author":"Thursby","year":"2017","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.canlet.2024.217096_bib29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1042\/CS20210778","article-title":"Gut microbiota-derived butyrate regulates gut mucus barrier repair by activating the macrophage\/WNT\/ERK signaling pathway","volume":"136","author":"Liang","year":"2022","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.canlet.2024.217096_bib30","article-title":"Gut microbiome and metabolites: the potential key roles in pulmonary fibrosis","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Microbiol."},{"issue":"20","key":"10.1016\/j.canlet.2024.217096_bib31","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.123.067547","article-title":"Unraveling the complex relationship between gut microbiome and cardiovascular diseases","volume":"149","author":"Tang","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib32","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2155018","article-title":"Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response","volume":"15","author":"Shen","year":"2023","journal-title":"Gut Microb."},{"key":"10.1016\/j.canlet.2024.217096_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.722730","article-title":"Modulation of the gut microbiota by sihocheonggan-Tang shapes the immune responses of atopic dermatitis","volume":"12","author":"Chun","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.canlet.2024.217096_bib34","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/advances\/nmz127","article-title":"Tryptophan metabolism: a link between the gut microbiota and brain","volume":"11","author":"Gao","year":"2020","journal-title":"Adv. Nutr."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib35","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1038\/s41467-020-19701-0","article-title":"Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease","volume":"11","author":"Bowerman","year":"2020","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.canlet.2024.217096_bib36","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.230014","article-title":"Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections","volume":"13","author":"Ney","year":"2023","journal-title":"Open Biol"},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrmicro.2016.142","article-title":"Emerging pathogenic links between microbiota and the gut-lung axis","volume":"15","author":"Budden","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"issue":"10","key":"10.1016\/j.canlet.2024.217096_bib38","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/gut.28.10.1221","article-title":"Short chain fatty acids in human large intestine, portal, hepatic and venous blood","volume":"28","author":"Cummings","year":"1987","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.canlet.2024.217096_bib39","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.canlet.2024.217096_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/nu12041107","article-title":"The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome","volume":"12","author":"Markowiak-Kopec","year":"2020","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1039\/D1FO02752B","article-title":"Saccharomyces boulardii alleviates DSS-induced intestinal barrier dysfunction and inflammation in humanized mice","volume":"13","author":"Li","year":"2022","journal-title":"Food Funct."},{"issue":"2","key":"10.1016\/j.canlet.2024.217096_bib42","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.immuni.2018.12.018","article-title":"The short chain fatty acid butyrate imprints an antimicrobial Program in macrophages","volume":"50","author":"Schulthess","year":"2019","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.canlet.2024.217096_bib43","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/s41590-019-0451-9","article-title":"The influence of the microbiome on respiratory health","volume":"20","author":"Wypych","year":"2019","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib44","doi-asserted-by":"crossref","first-page":"L65","DOI":"10.1152\/ajplung.00421.2020","article-title":"Lung immune tone via gut-lung axis: gut-derived LPS and short-chain fatty acids' immunometabolic regulation of lung IL-1beta, FFAR2, and FFAR3 expression","volume":"321","author":"Liu","year":"2021","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"5","key":"10.1016\/j.canlet.2024.217096_bib45","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/cea.13119","article-title":"Short-chain fatty acids induce tissue plasminogen activator in airway epithelial cells via GPR41&43","volume":"48","author":"Imoto","year":"2018","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.canlet.2024.217096_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fmed.2017.00061","article-title":"The future of Bronchopulmonary Dysplasia: emerging pathophysiological concepts and potential new Avenues of treatment","volume":"4","author":"Collins","year":"2017","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib47","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1038\/s41467-023-41536-8","article-title":"Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumonia","volume":"14","author":"Renga","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.canlet.2024.217096_bib48","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.chembiol.2015.02.005","article-title":"Biosynthetic manipulation of tryptophan in bacteria: pathways and mechanisms","volume":"22","author":"Alkhalaf","year":"2015","journal-title":"Chem Biol"},{"issue":"8","key":"10.1016\/j.canlet.2024.217096_bib49","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","article-title":"Tryptophan metabolism in health and disease","volume":"35","author":"Xue","year":"2023","journal-title":"Cell Metab"},{"issue":"7682","key":"10.1016\/j.canlet.2024.217096_bib50","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature24661","article-title":"A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites","volume":"551","author":"Dodd","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib51","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","article-title":"Microbial tryptophan catabolites in health and disease","volume":"9","author":"Roager","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.chom.2017.06.007","article-title":"Indoleacrylic acid produced by commensal peptostreptococcus species suppresses inflammation","volume":"22","author":"Wlodarska","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.canlet.2024.217096_bib53","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut microbiota regulation of tryptophan metabolism in health and disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"7980","key":"10.1016\/j.canlet.2024.217096_bib54","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/s41586-023-06287-y","article-title":"Endothelial AHR activity prevents lung barrier disruption in viral infection","volume":"621","author":"Major","year":"2023","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.canlet.2024.217096_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11041123","article-title":"N-carbamoylputrescine amidohydrolase of Bacteroides thetaiotaomicron, a dominant species of the human gut microbiota","volume":"11","author":"Shimokawa","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib56","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2203968","article-title":"Microbial metabolites in colorectal tumorigenesis and cancer therapy","volume":"15","author":"Liu","year":"2023","journal-title":"Gut Microb."},{"issue":"5","key":"10.1016\/j.canlet.2024.217096_bib57","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/jn\/130.5.1225","article-title":"The human gut bacteria Bacteroides thetaiotaomicron and Fusobacterium varium produce putrescine and spermidine in cecum of pectin-fed gnotobiotic rats","volume":"130","author":"Noack","year":"2000","journal-title":"J. Nutr."},{"key":"10.1016\/j.canlet.2024.217096_bib58","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fnut.2019.00016","article-title":"Polyamines and gut microbiota","volume":"6","author":"Tofalo","year":"2019","journal-title":"Front. Nutr."},{"issue":"2","key":"10.1016\/j.canlet.2024.217096_bib59","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.clnu.2004.11.001","article-title":"Polyamines: metabolism and implications in human diseases","volume":"24","author":"Moinard","year":"2005","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.canlet.2024.217096_bib60","doi-asserted-by":"crossref","first-page":"L417","DOI":"10.1152\/ajplung.2000.278.3.L417","article-title":"Polyamines in the lung: polyamine uptake and polyamine-linked pathological or toxicological conditions","volume":"278","author":"Hoet","year":"2000","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"3 Pt 1","key":"10.1016\/j.canlet.2024.217096_bib61","doi-asserted-by":"crossref","first-page":"C579","DOI":"10.1152\/ajpcell.1989.257.3.C579","article-title":"Localization of spermidine uptake in rabbit lung slices","volume":"257","author":"Saunders","year":"1989","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.canlet.2024.217096_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-024-00914-3","article-title":"The changing metabolic landscape of bile acids - keys to metabolism and immune regulation","author":"Mohanty","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.canlet.2024.217096_bib63","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib64","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41467-021-27758-8","article-title":"Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion","volume":"13","author":"Hu","year":"2022","journal-title":"Nat. Commun."},{"issue":"7813","key":"10.1016\/j.canlet.2024.217096_bib65","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","article-title":"A metabolic pathway for bile acid dehydroxylation by the gut microbiome","volume":"582","author":"Funabashi","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1854008","article-title":"The gut bacterium Extibacter muris produces secondary bile acids and influences liver physiology in gnotobiotic mice","volume":"13","author":"Streidl","year":"2021","journal-title":"Gut Microb."},{"issue":"11","key":"10.1016\/j.canlet.2024.217096_bib67","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1080\/13543784.2017.1385760","article-title":"Beneficial effects of bile acid receptor agonists in pulmonary disease models","volume":"26","author":"Comeglio","year":"2017","journal-title":"Expert Opin Investig Drugs"},{"issue":"6","key":"10.1016\/j.canlet.2024.217096_bib68","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/resp.12815","article-title":"Bile acids induce activation of alveolar epithelial cells and lung fibroblasts through farnesoid X receptor-dependent and independent pathways","volume":"21","author":"Chen","year":"2016","journal-title":"Respirology"},{"issue":"12","key":"10.1016\/j.canlet.2024.217096_bib69","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/all.12019","article-title":"Ursodeoxycholic acid suppresses eosinophilic airway inflammation by inhibiting the function of dendritic cells through the nuclear farnesoid X receptor","volume":"67","author":"Willart","year":"2012","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib70","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41575-023-00864-2","article-title":"The maternal gut microbiome in pregnancy: implications for the developing immune system","volume":"21","author":"Koren","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib71","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1038\/s41467-018-06473-x","article-title":"Meta-analysis of effects of exclusive breastfeeding on infant gut microbiota across populations","volume":"9","author":"Ho","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib72","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1039\/D1FO03131G","article-title":"Lactation-dependent vertical transmission of natural probiotics from the mother to the infant gut through breast milk","volume":"13","author":"Qi","year":"2022","journal-title":"Food Funct."},{"issue":"12","key":"10.1016\/j.canlet.2024.217096_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/nu12123783","article-title":"Lactobacillus bacteria in breast milk","volume":"12","author":"Lubiech","year":"2020","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.canlet.2024.217096_bib74","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/s41564-021-00970-4","article-title":"Bifidobacterium species associated with breastfeeding produce aromatic lactic acids in the infant gut","volume":"6","author":"Laursen","year":"2021","journal-title":"Nat Microbiol"},{"issue":"3","key":"10.1016\/j.canlet.2024.217096_bib75","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/mi.2017.118","article-title":"GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3","volume":"11","author":"Zhao","year":"2018","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib76","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12906-018-2408-1","article-title":"Therapeutic benefits of Indole-3-Carbinol in adjuvant-induced arthritis and its protective effect against methotrexate induced-hepatic toxicity","volume":"18","author":"Hasan","year":"2018","journal-title":"BMC Complement Altern Med"},{"issue":"10","key":"10.1016\/j.canlet.2024.217096_bib77","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41401-020-00573-5","article-title":"Probiotics protect against RSV infection by modulating the microbiota-alveolar-macrophage axis","volume":"42","author":"Ji","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.canlet.2024.217096_bib78","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3389\/fimmu.2020.01331","article-title":"Alterations in the gut microbiome and cecal metabolome during Klebsiella pneumoniae-induced Pneumosepsis","volume":"11","author":"Wu","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.canlet.2024.217096_bib79","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1016\/j.celrep.2020.02.013","article-title":"Gut Dysbiosis during influenza contributes to pulmonary pneumococcal superinfection through altered short-chain fatty acid production","volume":"30","author":"Sencio","year":"2020","journal-title":"Cell Rep."},{"issue":"13","key":"10.1016\/j.canlet.2024.217096_bib80","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1002\/jsfa.11207","article-title":"Both living and dead Faecalibacterium prausnitzii alleviate house dust mite-induced allergic asthma through the modulation of gut microbiota and short-chain fatty acid production","volume":"101","author":"Hu","year":"2021","journal-title":"J. Sci. Food Agric."},{"key":"10.1016\/j.canlet.2024.217096_bib81","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2147\/JAA.S354870","article-title":"Gut microbiome and metabolomics profiles of allergic and non-allergic childhood asthma","volume":"15","author":"Zheng","year":"2022","journal-title":"J. Asthma Allergy"},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib82","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1038\/s41467-019-11152-6","article-title":"Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response","volume":"10","author":"Antunes","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.canlet.2024.217096_bib83","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.3444","article-title":"Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis","volume":"20","author":"Trompette","year":"2014","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.canlet.2024.217096_bib84","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.immuni.2018.04.022","article-title":"Dietary fiber confers protection against Flu by shaping Ly6c(-) patrolling monocyte hematopoiesis and CD8(+) T cell metabolism","volume":"48","author":"Trompette","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2024.217096_bib85","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fmicb.2019.00159","article-title":"Elevated gut microbiome-derived propionate levels are associated with reduced sterile lung inflammation and bacterial immunity in mice","volume":"10","author":"Tian","year":"2019","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.canlet.2024.217096_bib86","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1073\/pnas.1322269111","article-title":"The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition","volume":"111","author":"Chang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.canlet.2024.217096_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115821","article-title":"The role and mechanism of action of microbiota-derived short-chain fatty acids in neutrophils: from the activation to becoming potential biomarkers","volume":"169","author":"Yan","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.canlet.2024.217096_bib88","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cmet.2021.03.002","article-title":"Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8(+) T cell immunity","volume":"33","author":"He","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.canlet.2024.217096_bib89","series-title":"Fat Digestion and Absorption","author":"Christophe","year":"2000"},{"key":"10.1016\/j.canlet.2024.217096_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106321","article-title":"The gut-lung axis in severe acute Pancreatitis-associated lung injury: the protection by the gut microbiota through short-chain fatty acids","volume":"182","author":"Wang","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2024.217096_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583042","article-title":"Cross-talk between alveolar macrophages and lung epithelial cells is essential to maintain lung homeostasis","volume":"11","author":"Bissonnette","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.canlet.2024.217096_bib92","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1096\/fj.201903089R","article-title":"Resident alveolar macrophage-derived vesicular SOCS3 dampens allergic airway inflammation","volume":"34","author":"Draijer","year":"2020","journal-title":"Faseb. J."},{"issue":"3","key":"10.1016\/j.canlet.2024.217096_bib93","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/mi.2017.75","article-title":"Microbiome-driven allergic lung inflammation is ameliorated by short-chain fatty acids","volume":"11","author":"Cait","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.canlet.2024.217096_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1330373","article-title":"Indole-3-carbinol attenuates lipopolysaccharide-induced acute respiratory distress syndrome through activation of AhR: role of CCR2+ monocyte activation and recruitment in the regulation of CXCR2+ neutrophils in the lungs","volume":"15","author":"Holloman","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib95","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12967-019-2043-8","article-title":"Aryl hydrocarbon receptor ligands enhance lung immunity through intestinal IKKbeta pathways","volume":"17","author":"Tsay","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2024.217096_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2020.12.026","article-title":"Prebiotic and probiotic supplementation and the tryptophan-kynurenine pathway: a systematic review and meta analysis","volume":"123","author":"Purton","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"Pt B","key":"10.1016\/j.canlet.2024.217096_bib97","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuropharm.2016.07.002","article-title":"Kynurenine pathway metabolism and the microbiota-gut-brain axis","volume":"112","author":"Kennedy","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.canlet.2024.217096_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107845","article-title":"Kynurenine emerges from the shadows - current knowledge on its fate and function","volume":"225","author":"Marszalek-Grabska","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib99","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00109-016-1474-4","article-title":"Interaction between gut microbiota and toll-like receptor: from immunity to metabolism","volume":"95","author":"Yiu","year":"2017","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.canlet.2024.217096_bib100","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3389\/fimmu.2017.00880","article-title":"The Ido-AhR Axis controls Th17\/Treg immunity in a pulmonary model of fungal infection","volume":"8","author":"de Araujo","year":"2017","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.canlet.2024.217096_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/foods13091336","article-title":"Gut microbiota-derived tryptophan metabolites alleviate allergic asthma inflammation in ovalbumin-induced mice","volume":"13","author":"Wang","year":"2024","journal-title":"Foods"},{"issue":"7","key":"10.1016\/j.canlet.2024.217096_bib102","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073758","article-title":"A focus on enterochromaffin cells among the Enteroendocrine cells: localization, morphology, and role","volume":"23","author":"Rezzani","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.canlet.2024.217096_bib103","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","article-title":"Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis","volume":"161","author":"Yano","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib104","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2073132","article-title":"Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection","volume":"14","author":"Kim","year":"2022","journal-title":"Gut Microb."},{"issue":"4","key":"10.1016\/j.canlet.2024.217096_bib105","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/00000658-200204000-00016","article-title":"Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury","volume":"235","author":"Liaudet","year":"2002","journal-title":"Ann. Surg."},{"issue":"7785","key":"10.1016\/j.canlet.2024.217096_bib106","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control T(H)17 and T(reg) cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2024.217096_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1091825","article-title":"Combined analysis of gut microbiome and serum metabolomics reveals novel biomarkers in patients with early-stage non-small cell lung cancer","volume":"13","author":"Ni","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.canlet.2024.217096_bib108","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev-physiol-021115-105221","article-title":"Ceramide signaling and metabolism in pathophysiological states of the lung","volume":"78","author":"Petrache","year":"2016","journal-title":"Annu. Rev. Physiol."},{"issue":"10","key":"10.1016\/j.canlet.2024.217096_bib109","first-page":"3171","article-title":"Alterations of fecal bacterial communities in patients with lung cancer","volume":"10","author":"Zhang","year":"2018","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.canlet.2024.217096_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1170326","article-title":"Structure of gut microbiota and characteristics of fecal metabolites in patients with lung cancer","volume":"13","author":"Lu","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217096_bib111","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12094-020-02421-8","article-title":"Comprehensive assessment of multiple tryptophan metabolites as potential biomarkers for immune checkpoint inhibitors in patients with non-small cell lung cancer","volume":"23","author":"Karayama","year":"2021","journal-title":"Clin. Transl. Oncol."},{"issue":"22","key":"10.1016\/j.canlet.2024.217096_bib112","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228730","article-title":"Network analysis of gut microbiome and metabolome to discover microbiota-linked biomarkers in patients affected by non-small cell lung cancer","volume":"21","author":"Vernocchi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.canlet.2024.217096_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21081040","article-title":"Polyamine metabolites profiling for characterization of lung and liver cancer using an LC-tandem MS method with multiple statistical data mining strategies: discovering potential cancer biomarkers in human plasma and urine","volume":"21","author":"Xu","year":"2016","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib114","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1038\/s41467-021-26685-y","article-title":"Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma","volume":"12","author":"Nie","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib115","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-38140-7","article-title":"Targeted metabolomic profiling as a tool for diagnostics of patients with non-small-cell lung cancer","volume":"13","author":"Shestakova","year":"2023","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.canlet.2024.217096_bib116","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jtho.2016.01.011","article-title":"Detection of lung cancer through metabolic changes measured in blood plasma","volume":"11","author":"Louis","year":"2016","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib117","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1038\/s41467-020-17347-6","article-title":"Machine learning of serum metabolic patterns encodes early-stage lung adenocarcinoma","volume":"11","author":"Huang","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib118","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/annonc\/mdv499","article-title":"Metabolic phenotyping of human blood plasma: a powerful tool to discriminate between cancer types?","volume":"27","author":"Louis","year":"2016","journal-title":"Ann. Oncol."},{"issue":"10","key":"10.1016\/j.canlet.2024.217096_bib119","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/bjc.2015.349","article-title":"Urinary N1, N12-diacetylspermine is a non-invasive marker for the diagnosis and prognosis of non-small-cell lung cancer","volume":"113","author":"Takahashi","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2024.217096_bib120","article-title":"Combined microbiome and metabolome analysis reveals a novel interplay between intestinal flora and serum metabolites in lung cancer","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"10","key":"10.1016\/j.canlet.2024.217096_bib121","doi-asserted-by":"crossref","first-page":"S1145","DOI":"10.1016\/j.jtho.2021.08.589","article-title":"P58. 01 dysbiosis of fecal microbiome in advanced non-small-cell lung cancer","volume":"16","author":"Chen","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.canlet.2024.217096_bib122","article-title":"Gut microbiota and its metabolites in non-small cell lung cancer and brain metastasis: from alteration to potential microbial markers and drug targets","volume":"13","author":"Jiang","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib123","doi-asserted-by":"crossref","first-page":"304","DOI":"10.21037\/tlcr-20-380","article-title":"High indoleamine-2,3-dioxygenase 1 (Ido) activity is linked to primary resistance to immunotherapy in non-small cell lung cancer (NSCLC)","volume":"10","author":"Kocher","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"issue":"2","key":"10.1016\/j.canlet.2024.217096_bib124","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/cas.15629","article-title":"Serum untargeted metabolomics reveal metabolic alteration of non-small cell lung cancer and refine disease detection","volume":"114","author":"Li","year":"2023","journal-title":"Cancer Sci."},{"issue":"19","key":"10.1016\/j.canlet.2024.217096_bib125","doi-asserted-by":"crossref","first-page":"17285","DOI":"10.1007\/s00432-023-05434-2","article-title":"Alteration of serum bile acids in non-small cell lung cancer identified by a validated LC-MS\/MS method","volume":"149","author":"Yin","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2024.217096_bib126","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1080\/19490976.2020.1737487","article-title":"Specific gut microbiome signature predicts the early-stage lung cancer","volume":"11","author":"Zheng","year":"2020","journal-title":"Gut Microb."},{"issue":"2","key":"10.1016\/j.canlet.2024.217096_bib127","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2249143","article-title":"Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell","volume":"15","author":"Zhu","year":"2023","journal-title":"Gut Microb."},{"issue":"14","key":"10.1016\/j.canlet.2024.217096_bib128","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/1759-7714.15303","article-title":"Gut microbiome affects the response to immunotherapy in non-small cell lung cancer","volume":"15","author":"Ren","year":"2024","journal-title":"Thorac Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2024.217096_bib129","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133501","article-title":"Combination of host immune metabolic biomarkers for the PD-1 blockade cancer immunotherapy","volume":"5","author":"Hatae","year":"2020","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.canlet.2024.217096_bib130","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/s41396-023-01483-0","article-title":"Potential effects of gut microbiota on host cancers: focus on immunity, DNA damage, cellular pathways, and anticancer therapy","volume":"17","author":"Sun","year":"2023","journal-title":"ISME J."},{"key":"10.1016\/j.canlet.2024.217096_bib131","article-title":"The role of gut microbiota in lung cancer: from carcinogenesis to immunotherapy","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.canlet.2024.217096_bib132","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1158\/2159-8290.CD-21-0324","article-title":"The cancer microbiome: recent highlights and knowledge gaps","volume":"11","author":"Knippel","year":"2021","journal-title":"Cancer Discov."},{"issue":"9","key":"10.1016\/j.canlet.2024.217096_bib133","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.21873\/anticanres.14484","article-title":"The role of the microbiome in cancer and therapy efficacy: focus on lung cancer","volume":"40","author":"Halley","year":"2020","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2024.217096_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216384","article-title":"Multi-omic analysis reveals metabolic pathways that characterize right-sided colon cancer liver metastasis","volume":"574","author":"Morris","year":"2023","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.canlet.2024.217096_bib135","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00018-022-04278-2","article-title":"The role of bile acids in carcinogenesis","volume":"79","author":"Rezen","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2024.217096_bib136","doi-asserted-by":"crossref","DOI":"10.1177\/15347354221114100","article-title":"Research on gut microbiota-derived secondary bile acids in cancer progression","volume":"21","author":"Yang","year":"2022","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.canlet.2024.217096_bib137","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.canlet.2017.10.017","article-title":"The membrane bile acid receptor TGR5 drives cell growth and migration via activation of the JAK2\/STAT3 signaling pathway in non-small cell lung cancer","volume":"412","author":"Liu","year":"2018","journal-title":"Cancer Lett."},{"issue":"18","key":"10.1016\/j.canlet.2024.217096_bib138","doi-asserted-by":"crossref","first-page":"18691","DOI":"10.1002\/cam4.6484","article-title":"The tryptophan-kynurenine pathway in immunomodulation and cancer metastasis","volume":"12","author":"Basson","year":"2023","journal-title":"Cancer Med."},{"issue":"3","key":"10.1016\/j.canlet.2024.217096_bib139","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030698","article-title":"Recent advances in metabolic pathways of sulfate reduction in intestinal bacteria","volume":"9","author":"Kushkevych","year":"2020","journal-title":"Cells"},{"issue":"24","key":"10.1016\/j.canlet.2024.217096_bib140","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27249005","article-title":"The role of hydrogen sulfide in the development and progression of lung cancer","volume":"27","author":"Yang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.canlet.2024.217096_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113775","article-title":"Hydrogen sulfide modulates epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via HIF-1alpha activation","volume":"172","author":"Wang","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217096_bib142","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.chom.2023.01.009","article-title":"Gut microbiome lipid metabolism and its impact on host physiology","volume":"31","author":"Brown","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.canlet.2024.217096_bib143","article-title":"Association between abnormal lipid metabolism and tumor","volume":"14","author":"Li","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.canlet.2024.217096_bib144","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jacl.2017.05.004","article-title":"Blood lipids profile and lung cancer risk in a meta-analysis of prospective cohort studies","volume":"11","author":"Lin","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"10","key":"10.1016\/j.canlet.2024.217096_bib145","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.devcel.2021.04.013","article-title":"Lipid metabolism in cancer: new perspectives and emerging mechanisms","volume":"56","author":"Broadfield","year":"2021","journal-title":"Dev. Cell"},{"key":"10.1016\/j.canlet.2024.217096_bib146","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.2147\/OTT.S252323","article-title":"Sodium butyrate combined with docetaxel for the treatment of lung adenocarcinoma A549 cells by targeting Gli1","volume":"13","author":"Chen","year":"2020","journal-title":"OncoTargets Ther."},{"issue":"4","key":"10.1016\/j.canlet.2024.217096_bib147","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1002\/jcb.26547","article-title":"Profiling and characterization of microRNAs responding to sodium butyrate treatment in A549 cells","volume":"119","author":"Xiao","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2024.217096_bib148","first-page":"83","article-title":"Molecular basis of sodium butyrate-dependent proapoptotic activity in cancer cells","volume":"52","author":"Pajak","year":"2007","journal-title":"Adv. Med. Sci."},{"issue":"2","key":"10.1016\/j.canlet.2024.217096_bib149","first-page":"1569","article-title":"Propionate of a microbiota metabolite induces cell apoptosis and cell cycle arrest in lung cancer","volume":"20","author":"Kim","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib150","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13578-023-01038-y","article-title":"FFAR2 antagonizes TLR2- and TLR3-induced lung cancer progression via the inhibition of AMPK-TAK1 signaling axis for the activation of NF-kappaB","volume":"13","author":"Kim","year":"2023","journal-title":"Cell Biosci."},{"issue":"9","key":"10.1016\/j.canlet.2024.217096_bib151","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1021\/acs.jafc.2c08889","article-title":"Gut bacteria involved in ellagic acid metabolism to yield human urolithin metabotypes revealed","volume":"71","author":"Iglesias-Aguirre","year":"2023","journal-title":"J. Agric. Food Chem."},{"issue":"7","key":"10.1016\/j.canlet.2024.217096_bib152","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1158\/0008-5472.CAN-21-0145","article-title":"Mdm2 and MdmX: partners in p53 destruction","volume":"81","author":"Manfredi","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.217096_bib153","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.2147\/OTT.S305595","article-title":"Urolithin A inhibits epithelial-mesenchymal transition in lung cancer cells via P53-mdm2-snail pathway","volume":"14","author":"Cheng","year":"2021","journal-title":"OncoTargets Ther."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib154","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","article-title":"Lung cancer immunotherapy: progress, pitfalls, and promises","volume":"22","author":"Lahiri","year":"2023","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.canlet.2024.217096_bib155","doi-asserted-by":"crossref","first-page":"354","DOI":"10.21037\/atm-22-4218","article-title":"Immune checkpoint inhibitors in non-small cell lung cancer: from current perspectives to future treatments-a systematic review","volume":"11","author":"Olivares-Hernandez","year":"2023","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib156","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13045-022-01273-9","article-title":"Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies","volume":"15","author":"Lu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2024.217096_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216318","article-title":"The opportunities and challenges in immunotherapy: insights from the regulation of PD-L1 in cancer cells","volume":"569","author":"Lin","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217096_bib158","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-024-02823-z","article-title":"A gut microbial signature for combination immune checkpoint blockade across cancer types","author":"Gunjur","year":"2024","journal-title":"Nat Med"},{"issue":"6371","key":"10.1016\/j.canlet.2024.217096_bib159","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.canlet.2024.217096_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107347","article-title":"Effect of antibiotic treatment on immune checkpoint inhibitors efficacy in patients with advanced non-small cell lung cancer","volume":"184","author":"Alkan Sen","year":"2023","journal-title":"Lung Cancer"},{"issue":"10","key":"10.1016\/j.canlet.2024.217096_bib161","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/2326-6066.CIR-20-0196","article-title":"The gut microbiome associates with immune checkpoint inhibition outcomes in patients with advanced non-small cell lung cancer","volume":"8","author":"Hakozaki","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"7741","key":"10.1016\/j.canlet.2024.217096_bib162","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41586-019-0878-z","article-title":"A defined commensal consortium elicits CD8 T cells and anti-cancer immunity","volume":"565","author":"Tanoue","year":"2019","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.canlet.2024.217096_bib163","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215401","article-title":"Exploring gut microbiome in predicting the efficacy of immunotherapy in non-small cell lung cancer","volume":"14","author":"Liu","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.canlet.2024.217096_bib164","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/1759-7714.13442","article-title":"Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese NSCLC patients","volume":"11","author":"Song","year":"2020","journal-title":"Thorac Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2024.217096_bib165","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.2895","article-title":"Association of short-chain fatty acids in the gut microbiome with clinical response to treatment with nivolumab or pembrolizumab in patients with solid cancer tumors","volume":"3","author":"Nomura","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib166","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mi.2014.44","article-title":"Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway","volume":"8","author":"Park","year":"2015","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.canlet.2024.217096_bib167","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3389\/fimmu.2020.01243","article-title":"Tryptophan catabolism as immune mechanism of primary resistance to anti-PD-1","volume":"11","author":"Botticelli","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.canlet.2024.217096_bib168","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002840","article-title":"Tryptophan potentiates CD8(+) T cells against cancer cells by TRIP12 tryptophanylation and surface PD-1 downregulation","volume":"9","author":"Qin","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.canlet.2024.217096_bib169","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejca.2018.06.020","article-title":"Indoleamine 2,3-dioxygenase 1 and programmed cell death-ligand 1 co-expression correlates with aggressive features in lung adenocarcinoma","volume":"101","author":"Kozuma","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2024.217096_bib170","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3389\/fimmu.2019.01973","article-title":"Engagement of nuclear coactivator 7 by 3-Hydroxyanthranilic acid enhances activation of aryl hydrocarbon receptor in immunoregulatory dendritic cells","volume":"10","author":"Gargaro","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib171","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41598-023-51108-x","article-title":"Immune, metabolic landscapes of prognostic signatures for lung adenocarcinoma based on a novel deep learning framework","volume":"14","author":"Qin","year":"2024","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.canlet.2024.217096_bib172","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1111\/1759-7714.14626","article-title":"Gut microbiota shed new light on the management of immune-related adverse events","volume":"13","author":"Tan","year":"2022","journal-title":"Thorac Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib173","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1186\/s12885-021-08530-z","article-title":"Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer","volume":"21","author":"Chau","year":"2021","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2024.217096_bib174","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032769","article-title":"Implication of the gut microbiome and microbial-derived metabolites in immune-related adverse events: emergence of novel biomarkers for cancer immunotherapy","volume":"24","author":"Dora","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-021-02201-4","article-title":"Prevotellaceae produces butyrate to alleviate PD-1\/PD-L1 inhibitor-related cardiotoxicity via PPARalpha-CYP4X1 axis in colonic macrophages","volume":"41","author":"Chen","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2024.217096_bib176","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003725","article-title":"Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite","volume":"10","author":"Renga","year":"2022","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib177","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13073-024-01285-9","article-title":"Gut microbiome for predicting immune checkpoint blockade-associated adverse events","volume":"16","author":"Hu","year":"2024","journal-title":"Genome Med."},{"issue":"3","key":"10.1016\/j.canlet.2024.217096_bib178","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jamaoncol.2017.2925","article-title":"Association of immune-related adverse events with nivolumab efficacy in non-small-cell lung cancer","volume":"4","author":"Haratani","year":"2018","journal-title":"JAMA Oncol."},{"issue":"7","key":"10.1016\/j.canlet.2024.217096_bib179","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.cell.2024.02.022","article-title":"Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer","volume":"187","author":"Jia","year":"2024","journal-title":"Cell"},{"issue":"75","key":"10.1016\/j.canlet.2024.217096_bib180","doi-asserted-by":"crossref","first-page":"eabn0704","DOI":"10.1126\/sciimmunol.abn0704","article-title":"The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer","volume":"7","author":"Mirji","year":"2022","journal-title":"Sci Immunol"},{"issue":"6558","key":"10.1016\/j.canlet.2024.217096_bib181","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1126\/science.abc9113","article-title":"Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy","volume":"373","author":"Griffin","year":"2021","journal-title":"Science"},{"issue":"6510","key":"10.1016\/j.canlet.2024.217096_bib182","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.abc3421","article-title":"Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy","volume":"369","author":"Mager","year":"2020","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.canlet.2024.217096_bib183","article-title":"Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: an emerging trend in cancer patient care","volume":"1878","author":"Ciernikova","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"issue":"2","key":"10.1016\/j.canlet.2024.217096_bib184","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2019.4107","article-title":"Association of dietary fiber and yogurt consumption with lung cancer risk: a pooled analysis","volume":"6","author":"Yang","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2024.217096_bib185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejca.2020.07.026","article-title":"Role of the gut microbiome for cancer patients receiving immunotherapy: dietary and treatment implications","volume":"138","author":"Lee","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2024.217096_bib186","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00253-021-11646-8","article-title":"Probiotics, prebiotics and synbiotics: safe options for next-generation therapeutics","volume":"106","author":"Yadav","year":"2022","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217096_bib187","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ijc.33557","article-title":"Clinical impact of probiotics on the efficacy of anti-PD-1 monotherapy in patients with nonsmall cell lung cancer: a multicenter retrospective survival analysis study with inverse probability of treatment weighting","volume":"149","author":"Takada","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.canlet.2024.217096_bib188","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/ijc.34842","article-title":"Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non-small-cell lung cancer","volume":"154","author":"Morita","year":"2024","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2024.217096_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104533","article-title":"Lacticaseibacillus rhamnosus Probio-M9 enhanced the antitumor response to anti-PD-1 therapy by modulating intestinal metabolites","volume":"91","author":"Gao","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.canlet.2024.217096_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110625","article-title":"Immune boosting functional foods and their mechanisms: a critical evaluation of probiotics and prebiotics","volume":"130","author":"Ashaolu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2024.217096_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2020.109473","article-title":"Health promoting microbial metabolites produced by gut microbiota after prebiotics metabolism","volume":"136","author":"Peredo-Lovillo","year":"2020","journal-title":"Food Res. Int."},{"issue":"8","key":"10.1016\/j.canlet.2024.217096_bib192","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1007\/s13197-020-04244-5","article-title":"Prebiotics metabolism by gut-isolated probiotics","volume":"57","author":"Rawi","year":"2020","journal-title":"J. Food Sci. Technol."},{"issue":"11","key":"10.1016\/j.canlet.2024.217096_bib193","doi-asserted-by":"crossref","DOI":"10.3390\/biom12111636","article-title":"Curcumin and its analogs in non-small cell lung cancer treatment: challenges and expectations","volume":"12","author":"Tang","year":"2022","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.canlet.2024.217096_bib194","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9091086","article-title":"The role of curcumin in cancer treatment","volume":"9","author":"Zoi","year":"2021","journal-title":"Biomedicines"},{"issue":"22","key":"10.1016\/j.canlet.2024.217096_bib195","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14225577","article-title":"Interactions between dietary Micronutrients, composition of the microbiome and efficacy of immunotherapy in cancer patients","volume":"14","author":"Frak","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2024.217096_bib196","series-title":"Synbiotics for the Management of Cancer","first-page":"191","article-title":"Synbiotics in lung cancer","author":"Prakash","year":"2023"},{"issue":"6","key":"10.1016\/j.canlet.2024.217096_bib197","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00262-024-03686-6","article-title":"Synergistic immunomodulatory effect of synbiotics pre- and postoperative resection of pancreatic ductal adenocarcinoma: a randomized controlled study","volume":"73","author":"Maher","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2024.217096_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111009","article-title":"Revolutionizing lung health: exploring the latest breakthroughs and future prospects of synbiotic nanostructures in lung diseases","volume":"395","author":"Bani Saeid","year":"2024","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"10.1016\/j.canlet.2024.217096_bib199","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.chom.2023.03.020","article-title":"Key determinants of success in fecal microbiota transplantation: from microbiome to clinic","volume":"31","author":"Porcari","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"7","key":"10.1016\/j.canlet.2024.217096_bib200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25073768","article-title":"Dynamic changes of the gut microbiota and its functional metagenomic potential during the development of non-small cell lung cancer","volume":"25","author":"Feng","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"35","key":"10.1016\/j.canlet.2024.217096_bib201","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202301097","article-title":"The next generation fecal microbiota transplantation: to transplant bacteria or virome","volume":"10","author":"Yu","year":"2023","journal-title":"Adv. Sci."},{"issue":"6529","key":"10.1016\/j.canlet.2024.217096_bib202","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.canlet.2024.217096_bib203","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41591-023-02453-x","article-title":"Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial","volume":"29","author":"Routy","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.canlet.2024.217096_bib204","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104967","article-title":"Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy","volume":"100","author":"Yang","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.canlet.2024.217096_bib205","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2022.127053","article-title":"Insights into applications and strategies for discovery of microbial bioactive metabolites","volume":"261","author":"Maithani","year":"2022","journal-title":"Microbiol. Res."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11274-019-2775-x","article-title":"Harnessing microbial metabolomics for industrial applications","volume":"36","author":"Zhao","year":"2019","journal-title":"World J. Microbiol. Biotechnol."},{"issue":"11","key":"10.1016\/j.canlet.2024.217096_bib207","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1007\/s00253-020-10587-y","article-title":"Yeast metabolic engineering for the production of pharmaceutically important secondary metabolites","volume":"104","author":"Rahmat","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib208","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cmet.2021.12.011","article-title":"Emerging targetome and signalome landscape of gut microbial metabolites","volume":"34","author":"Zheng","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.canlet.2024.217096_bib209","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216423","article-title":"Novel strategies optimize immunotherapy by improving the cytotoxic function of T cells for pancreatic cancer treatment","volume":"576","author":"Luo","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217096_bib210","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216038","article-title":"Immune checkpoint inhibitor resistance in hepatocellular carcinoma","volume":"555","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"issue":"32","key":"10.1016\/j.canlet.2024.217096_bib211","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1200\/JCO.2018.78.9602","article-title":"Epacadostat plus pembrolizumab in patients with advanced solid tumors: phase I results from a multicenter, open-label phase I\/II trial (ECHO-202\/KEYNOTE-037)","volume":"36","author":"Mitchell","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2024.217096_bib212","doi-asserted-by":"crossref","DOI":"10.1007\/s10637-024-01422-6","article-title":"KEYNOTE-434 part B: a phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non-small-cell lung cancer","author":"Yamamoto","year":"2024","journal-title":"Invest New Drugs"},{"issue":"8","key":"10.1016\/j.canlet.2024.217096_bib213","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1470-2045(19)30274-8","article-title":"Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): a phase 3, randomised, double-blind study","volume":"20","author":"Long","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2024.217096_bib214","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121018","article-title":"Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy","volume":"276","author":"Guo","year":"2021","journal-title":"Biomaterials"},{"issue":"16","key":"10.1016\/j.canlet.2024.217096_bib215","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1158\/1078-0432.CCR-15-2584","article-title":"HDAC inhibitors enhance T-cell chemokine expression and augment response to PD-1 immunotherapy in lung adenocarcinoma","volume":"22","author":"Zheng","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"10.1016\/j.canlet.2024.217096_bib216","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1158\/1078-0432.CCR-17-0741","article-title":"Entinostat neutralizes myeloid-derived suppressor cells and enhances the antitumor effect of PD-1 inhibition in murine models of lung and renal cell carcinoma","volume":"23","author":"Orillion","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"22","key":"10.1016\/j.canlet.2024.217096_bib217","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1158\/1078-0432.CCR-19-1305","article-title":"Phase I\/ib study of pembrolizumab plus vorinostat in advanced\/metastatic non-small cell lung cancer","volume":"25","author":"Gray","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2024.217096_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216121","article-title":"The impact of histone deacetylase inhibitors on immune cells and implications for cancer therapy","volume":"559","author":"Moran","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217096_bib219","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114644","article-title":"Review on the effect of chemotherapy on the intestinal barrier: epithelial permeability, mucus and bacterial translocation","volume":"162","author":"Dahlgren","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2024.217096_bib220","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216236","article-title":"Metronomic chemotherapy as a potential partner of immune checkpoint inhibitors for metastatic colorectal cancer treatment","volume":"565","author":"Hong","year":"2023","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.canlet.2024.217096_bib221","first-page":"2836","article-title":"Effects of probiotics on chemotherapy in patients with lung cancer","volume":"17","author":"Tian","year":"2019","journal-title":"Oncol. Lett."},{"issue":"8","key":"10.1016\/j.canlet.2024.217096_bib222","doi-asserted-by":"crossref","DOI":"10.3390\/nu13082792","article-title":"Administration of Lactobacillus reuteri combined with Clostridium butyricum attenuates cisplatin-induced renal damage by gut microbiota reconstitution, increasing butyric acid production, and suppressing renal inflammation","volume":"13","author":"Hsiao","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.canlet.2024.217096_bib223","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41392-022-01102-y","article-title":"Radiotherapy combined with immunotherapy: the dawn of cancer treatment","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.canlet.2024.217096_bib224","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216108","article-title":"Radiotherapy-induced tumor physical microenvironment remodeling to overcome immunotherapy resistance","volume":"559","author":"Peng","year":"2023","journal-title":"Cancer Lett."},{"issue":"21","key":"10.1016\/j.canlet.2024.217096_bib225","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111436","article-title":"Gut microbiota-derived l-histidine\/imidazole propionate Axis fights against the radiation-induced cardiopulmonary injury","volume":"22","author":"Chen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2024.217096_bib226","article-title":"Prediction of the mechanism of sodium butyrate against radiation-induced lung injury in non-small cell lung cancer based on network pharmacology and molecular dynamic simulations and molecular dynamic simulations","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2024.217096_bib227","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.chom.2018.11.002","article-title":"Microbiota-derived lactate accelerates intestinal stem-cell-mediated epithelial development","volume":"24","author":"Lee","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"11","key":"10.1016\/j.canlet.2024.217096_bib228","first-page":"3508","article-title":"The protective role of short-chain fatty acids acting as signal molecules in chemotherapy- or radiation-induced intestinal inflammation","volume":"10","author":"Tian","year":"2020","journal-title":"Am. J. Cancer Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524004919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524004919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T19:39:49Z","timestamp":1760816389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524004919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":228,"alternative-id":["S0304383524004919"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217096","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbial metabolites in lung cancer development and immunotherapy: Novel insights into gut-lung axis","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"217096"}}